A murine photothrombotic stroke model with an increased fibrin content and improved responses to tPA-lytic treatment
Open Access
- 30 March 2020
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 4 (7) , 1222-1231
Abstract
The Rose Bengal (RB) dye-based photothrombotic stroke (PTS) model has many methodological advantages including consistent location and size of infarct, low mortality, and relatively simple surgical procedures. However, the standard PTS has the caveat of poor responses to tissue-type plasminogen activator (tPA)–mediated lytic treatment, likely as a result of the platelet-rich, fibrin-poor content of the blood clots. Here we tested whether the admixture of thrombin (80 U/kg) and RB dye (50 mg/kg) in the proximal middle cerebral artery (MCA)–targeted PTS will modify the clot composition and elevate the responsiveness to tPA-lytic treatment (Alteplase, 10 mg/kg). Indeed, intravital imaging, immunostaining, and immunoblot analyses showed less-compacted platelet aggregates with a higher fibrin content in the modified thrombin (T) plus RB photothrombotic stroke (T+RB-PTS) model compared with the standard RB-PTS-induced clots. Both RB-PTS and T+RB-PTS showed steady recovery of cerebral blood flow (CBF) in the ischemic border from 1 day after infarction, but without recanalization of the proximal MCA branch. Intravital imaging showed high potency of restoring the blood flow by tPA after single vessel-targeted T+RB-PTS. Further, although intravenous tPA failed to restore CBF or attenuate infarction in RB-PTS, it conferred 25% recovery of CBF and 55% reduction of the infarct size in T+RB-PTS (P < .05) if tPA was administered within 2 hours postphotoactivation. These results suggest that T+RB-PTS produces mixed platelet:fibrin clots closer to the clinical thrombus composition and enhanced the sensitivity to tPA-lytic treatment. As such, the modified photothrombosis may be a useful tool to develop more effective thrombolytic therapies of cerebral ischemia.Keywords
This publication has 30 references indexed in Scilit:
- Pharmacological Modulation of Neutrophil Extracellular Traps Reverses Thrombotic Stroke tPA (Tissue-Type Plasminogen Activator) ResistanceStroke, 2019
- Cerebral Collateral Circulation: A Review in the Context of Ischemic Stroke and Mechanical ThrombectomyWorld Neurosurgery, 2019
- Current and future antiplatelet therapies: emphasis on preserving haemostasisNature Reviews Cardiology, 2018
- Sickle Mice Are Sensitive to Hypoxia/Ischemia-Induced Stroke but Respond to Tissue-Type Plasminogen Activator TreatmentStroke, 2017
- Potent Thrombolytic Effect of N -Acetylcysteine on Arterial ThrombiCirculation, 2017
- Ischemic StrokeStroke, 2017
- The Two Pathophysiologies of Focal Brain Ischemia: Implications for Translational Stroke ResearchJournal of Cerebral Blood Flow & Metabolism, 2012
- The Impact of Recanalization on Ischemic Stroke OutcomeStroke, 2007
- Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouseNature Medicine, 2002
- Cerebral Blood Flow Restoration and Reperfusion Injury After Ultraviolet Laser–Facilitated Middle Cerebral Artery Recanalization in Rat Thrombotic StrokeStroke, 2002